Status:
ENROLLING_BY_INVITATION
Imaging Biomarkers for Myofascial Pain
Lead Sponsor:
George Mason University
Conditions:
Myofascial Pain Syndrome
Healthy
Eligibility:
All Genders
18+ years
Brief Summary
Myofascial pain syndrome (MPS) is highly prevalent in the community. It is primarily diagnosed using patient self reports and physical examination, which lack reliability, sensitivity and specificity ...
Detailed Description
Definition of proposed composite multimodal biomarker-The investigators propose to develop a quantitative tissue-level classifier based on quantitative metrics (features) derived from ultrasound elast...
Eligibility Criteria
Inclusion
- Age 18 and older
Exclusion
- Diagnosis of fibromyalgia, chronic fatigue syndrome or chronic Lyme disease confirmed by physical exam
- Diagnosis of cervical radiculopathy, neuropathy or neuriitis
- History of head, neck, or shoulder girdle surgery
- Atypical facial neuralgia
- New medication or change in medication in past 6 months
- Current throat or ear infection
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT06060925
Start Date
January 1 2023
End Date
September 1 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
George Mason University
Fairfax, Virginia, United States, 22030